| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Lee Gary K. is a Chief Scientific Officer at Lyell Immunopharma, Inc.. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $327K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | LYEL Lyell Immunopharma, Inc. | Chief Scientific Officer | Sell | 1,671 | $23.39 | $39,084.69 | -9.0% | - | - | |
| Feb 10, 2026 | LYEL Lyell Immunopharma, Inc. | Chief Scientific Officer | Sell | 147 | $23.12 | $3,398.64 | -0.8% | - | - | |
| Nov 10, 2025 | LYEL Lyell Immunopharma, Inc. | Chief Scientific Officer | Sell | 138 | $16.16 | $2,230.08 | -0.9% | +31.5% | - | |
| Aug 21, 2025 | LYEL Lyell Immunopharma, Inc. | Chief Scientific Officer | Sell | 1,453 | $10.54 | $15,320.43 | -8.6% | +61.7% | - | |
| Aug 12, 2025 | LYEL Lyell Immunopharma, Inc. | Chief Scientific Officer | Sell | 267 | $10.43 | $2,784.87 | -1.5% | +67.3% | - |